Migraine trials recruiting in Illinois

All Migraine trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
  NCT07674654 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, Flossmoor, Naperville
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
  NCT07645924 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago, Flossmoor, Naperville
• Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
  NCT06904287 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Oak Lawn
• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  NCT05156398 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago
• Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
  NCT04743141 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago, Naperville
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  NCT04649242 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago, Naperville
• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
  NCT05125302 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Illinois: Chicago, Hoffman Estates
• Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
  NCT07310290 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Naperville